Loading...

Hybrid ultrasound-activated nanoparticles based on graphene quantum dots for cancer treatment

Ramedani, A ; Sharif University of Technology | 2022

42 Viewed
  1. Type of Document: Article
  2. DOI: 10.1016/j.ijpharm.2022.122373
  3. Publisher: Elsevier B.V , 2022
  4. Abstract:
  5. Theranostic liposomes have recently found a broad range of applications in nanomedicine due to stability, the high solubility of biomacromolecules, bioavailability, efficacy, and low adverse effects. However, the limitations of liposomes concerning the short systemic circulation in the body, limited controllability of the release rate, and the inability of in vivo imaging remain challenging. Herein, the development of novel hybrid ultrasound-activated piezoelectric nanoparticles based on a hybrid liposome nanocarrier composed of poly(vinylidene fluoride‐trifluoroethylene), graphene quantum dots (GQDs), and Silibinin (a hydrophobic drug) is presented. The hybrid nanoparticles are an acoustically sensitive drug delivery platform that releases the biomacromolecules in a specific tissue area (through surface labeling with PD-1 antibody) in a non-invasive and controlled manner. We show that the developed hybrid nanoparticles (with an average outer diameter of ∼ 230 ± 20 nm) enable piezoelectric-stimulated drug delivery combined with simultaneous fluorescent imaging of cancer cells in vivo. Significant enhancement (>80 % up to 240 h) and tunable drug release from the nanocarrier through enhanced diffusion from the liposome membrane are demonstrated. Cytotoxicity assays using MCF-7, 4T1, and NIH3T3 cell lines exhibit no confrontational influence of nanoparticles on cell viability up to 125 µg/ml. The PD-1 antibody on the surface of the hybrid nanocarrier allows for selective delivery to breast cancer tumors and low biodistribution to other tissues. Our results affirm that the developed ultrasound-activated piezoelectric nanoparticles have great potential as multifunctional platforms with sustainable release profiles for the delivery of hydrophobic drugs to breast cancer, especially when the ability for adequate labeling and cell monitoring is valued. © 2022 Elsevier B.V
  6. Keywords:
  7. Breast cancer ; Graphene quantum dot ; Liposome ; Stimuli-responsive polymer ; Theranostic agents ; nanoparticle ; programmed death 1 receptor ; quantum dot ; animal ; breast tumor ; chemistry ; drug delivery system ; human ; mouse ; NIH 3T3 cell line ; Animals ; Breast Neoplasms ; Drug Delivery Systems ; Female ; Graphite ; Humans ; Liposomes ; Mice ; Nanoparticles ; NIH 3T3 Cells ; Programmed Cell Death 1 Receptor ; Quantum Dots ; Tissue Distribution
  8. Source: International Journal of Pharmaceutics ; Volume 629 , 2022 ; 03785173 (ISSN)
  9. URL: https://www.sciencedirect.com/science/article/abs/pii/S0378517322009280